Valuing a company with no revenue is one of the hardest conversations in early-stage fundraising. Without historical financials to anchor a discounted cash flow model, founders and investors instead lean on a handful of heuristic methods built specifically for pre-revenue and early-revenue companies. Three of the most widely used are the Scorecard Method, the Berkus Method, and the Venture Capital (VC) Method. Each approaches the valuation problem differently, and understanding all three helps founders negotiate from an informed position.
The Scorecard Method
The Scorecard Method, popularized by angel investor Bill Payne, starts with the average pre-money valuation of recently funded companies in the same region and sector, then adjusts that baseline up or down based on a weighted comparison across factors such as management team strength, market size, product or technology, competitive environment, marketing and sales channels, and the need for additional investment. Each factor is assigned a percentage weight and a founder's company is scored relative to the "average" deal, producing a multiplier applied to the baseline valuation. This method is common in angel investor networks because it forces a structured, comparative conversation rather than a single arbitrary number.
In practice, an investor applying the Scorecard Method will first research what similar companies in the same geography and sector have recently raised at, since local and sector baselines can vary significantly. A seed-stage fintech company in a major hub, for example, might be benchmarked against a different average than a consumer hardware company in a smaller market. Once that baseline is set, the comparative scoring exercise becomes a useful diagnostic tool for founders: a low score on "management team" or "competitive environment" signals exactly where an investor's underwriting concerns lie, which gives founders a concrete list of gaps to address before the next round rather than a vague sense that the valuation was "too low."
The Berkus Method
Angel investor Dave Berkus developed his method specifically to avoid over-relying on financial projections, which are inherently speculative for pre-revenue companies — as Berkus himself has noted, fewer than one in a thousand startups meet or exceed their projected revenues in the periods they planned for. Instead, the Berkus Method assigns a dollar value, up to $500,000 each, to five qualitative risk-reduction factors: a sound idea, a working prototype that reduces product risk, quality of the management team, strategic relationships that reduce market risk, and evidence of product rollout or early sales. Summing these values produces a pre-money valuation, typically capped around $2 million pre-revenue or $2.5 million once a product has shipped. The method is intentionally simple and works best for seed-stage software and consumer companies rather than capital-intensive sectors like biotech, where the relevant valuation drivers covered in our piece on valuation models for biotechnology startups are quite different, given multi-year clinical timelines and regulatory milestones that have no real analog in Berkus's framework.
What makes the Berkus Method durable nearly three decades after it was first published is that it explicitly rewards risk reduction rather than growth projections. A founder who has shipped a working prototype, landed a strategic pilot customer, or built a credible founding team has objectively reduced the odds of failure, and the method translates that progress into dollars without requiring anyone to pretend they can forecast year-three revenue with any precision. Investors who use Berkus alongside Scorecard often find the two methods converge on a similar range, which is itself a useful sanity check before a term sheet is drafted.
The Venture Capital Method
The VC Method, originally articulated by Harvard Business School's William Sahlman, works backward from an expected future outcome. An investor estimates the company's terminal (exit) value in five to seven years, applies an expected return multiple to account for risk and the cost of capital, and derives the implied post-money valuation today. Working further back, dividing the amount being invested by that implied valuation reveals the ownership stake required. We go into this approach in detail in our dedicated article on the venture capital method, including how to think about exit multiples and dilution across future rounds.
Because the VC Method depends on an assumed exit value and target return multiple, small changes to those two inputs can swing the resulting valuation dramatically. A fund targeting a 10x return on a projected $100 million exit will demand a very different ownership percentage than one targeting a 20x return on the same exit assumption. Founders should ask directly what exit multiple and timeline an investor is using, since that single conversation often explains more about a term sheet's valuation than anything else discussed in the room.
Comparing the three methods
Scorecard and Berkus are both comparative, qualitative frameworks best suited to very early, pre-seed and seed-stage companies where there is little data to model. The VC Method, by contrast, requires a founder to make explicit assumptions about exit value and future dilution, which makes it more analytically rigorous but also more sensitive to assumptions that can be challenged in negotiation. In practice, many investors triangulate: they might use Scorecard or Berkus to sanity-check a round's price, then apply the VC Method to confirm the resulting ownership stake supports their fund's return targets. None of the three methods is "correct" in an absolute sense — each is a structured way of converting qualitative judgment into a number that both sides can anchor a negotiation around.
It is also worth noting that these methods are rarely used in isolation once a company has any revenue at all. As soon as there is a meaningful customer base or recurring revenue, investors tend to shift toward multiples of revenue or growth-adjusted multiples benchmarked against comparable public and private companies. Founders should think of Scorecard, Berkus, and the VC Method as bridge tools for the earliest stages of a company's life, not permanent valuation frameworks.
Practical tips for founders
Whichever method your prospective investor leans on, you should walk into the conversation with your own point of view on valuation, not just a number borrowed from a blog post. Build a clean cap table model before the round so you can see how each methodology's output affects your post-financing ownership and how much runway it buys relative to your milestones. It is also worth understanding how liquidation preferences interact with valuation, since a higher headline valuation paired with aggressive preference terms can leave founders worse off than a lower valuation with clean terms.
Founders should also come prepared with evidence that speaks directly to whichever factors their investor is likely to weight most heavily. If you expect a Berkus-style conversation, have a clear, demoable prototype and documented evidence of any strategic relationships or early customer commitments. If you expect a Scorecard conversation, know your comparable financings cold — recent round sizes and valuations for companies at a similar stage in your sector and geography — so you can push back if an investor's baseline seems stale or drawn from the wrong comparison set. And if you expect a VC Method conversation, build your own simple model of exit scenarios and dilution across future rounds so you are not simply accepting an investor's assumptions at face value.
Closing thoughts
No single formula will give you a "correct" valuation for a pre-revenue company — these methods exist to create a defensible, structured starting point for negotiation. If you are preparing for a pre-seed or seed raise and want help building a valuation narrative that will hold up with investors, book a free consult with Quantum Growth Advisors.